Home
Categories
EXPLORE
True Crime
Music
History
Society & Culture
Comedy
Business
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/77/b6/27/77b62731-cbf4-c23e-55ba-e0a8dd068b79/mza_17279697081413539006.png/600x600bb.jpg
Prostate Cancer Update
Dr. Neil Love
46 episodes
2 weeks ago
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.
Show more...
Science
Education,
Health & Fitness,
Medicine
RSS
All content for Prostate Cancer Update is the property of Dr. Neil Love and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.
Show more...
Science
Education,
Health & Fitness,
Medicine
https://artwork.captivate.fm/97635d70-f91b-4542-ac9e-4ad77eab0c7d/HDx77o9GuXjm3JsutW_azrxg.png
Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
Prostate Cancer Update
53 minutes 35 seconds
1 year ago
Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer.
Prostate Cancer Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.